dc.contributor.author |
Premathilaka, L.H.R.A. |
|
dc.contributor.author |
Lakmini, M.S. |
|
dc.contributor.author |
Thamal Dharshana, L.G. |
|
dc.contributor.author |
Nawaratne, S.B. |
|
dc.contributor.author |
Mettananda, S. |
|
dc.contributor.author |
de Silva, S.T. |
|
dc.contributor.author |
Premawardhena, A.P. |
|
dc.date.accessioned |
2018-02-08T04:36:22Z |
|
dc.date.available |
2018-02-08T04:36:22Z |
|
dc.date.issued |
2017 |
|
dc.identifier.citation |
Sri Lanka Journal of Medicine.2017;26(2):55–57 |
en_US |
dc.identifier.issn |
2579-1990 |
|
dc.identifier.uri |
http://repository.kln.ac.lk/handle/123456789/18601 |
|
dc.description.abstract |
Stroke in Sickle cell disease is a devastating complication. As Sickle cell disease is uncommon in Sri Lanka many clinicians may be unfamiliar with management of the disease and its complications. A 10-year-old boy presented with a transient ischaemic attack. He has had a silent large parietal infarct previously. He had been managed with transfusions and had undergone a splenectomy. However, he had not received hydroxyurea or undergone trans-cranial Doppler assessment. |
en_US |
dc.language.iso |
en_US |
en_US |
dc.publisher |
Kandy Society of Medicine |
en_US |
dc.subject |
Sickle beta thalassemia |
en_US |
dc.title |
Stroke in sickle cell beta thalassemia - a case report highlighting pitfalls in management in a low prevalence country |
en_US |
dc.type |
Article |
en_US |